PURACAP
associated with 14 other trademarks
Pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, ...

Words that describe this trademark:

disease endocrine system  hypertension cardiovascular disease  endocrine system  cardiovascular disease  treatment seizures  disease disease  system  gastroenterological  seizures  pharmaceuticals 

Serial Number:

85061783

Mark:

PURACAP

Status:

Cancelled-Section 8

Status Date:

09-23-2022

Filing Date:

Registration Number:

4112489

Registration Date:

03-13-2012

Goods and Services:

Pharmaceuticals for use in treatment of seizures, hypertension, cardiovascular disease, disease of the endocrine system, gastroenterological disease, hematological disease, infectious disease, disease of the immune system, musculoskeletal disease, kidney disease, disease of the nervous system, gynecological disease, cancer, diseases of the eye, ear, nose and throat, mental illness, rheumatological disease, bone disease, skin wounds, contact dermatitis, headaches, migraine headaches, muscle pain, inflammation, and for use in dental, cosmetic, maxillofacial, and plastic surgery, all available as tablets, capsules, softgels, liquids, creams, and powders

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

11-23-2010

Mark Drawing Status:

Standart Character Mark

Abandon Date:

N/A

Business Name:

FOX ROTHSCHILD LLP

Correspondent Name:

Recent Trademark filings by this company